Last Updated: September 19, 2026
A 340B cash start-up program is a contract pharmacy arrangement that pays a covered entity a fixed percentage of monthly claims as a cash advance the following month, whether or not those claims have collected. In programs we run, it exists because a new contract pharmacy relationship takes months to produce cash.
Picture a hypothetical clinic billing $40,000 in 340B claims in month one. At a 15% advance, the start-up program pays $6,000 the next month.
Most start-up terms share the same structure:
The percent is not a fee. It is a prepayment against future collections.
The cumulative over/under balance grows in the ramp months and flips once trailing A/R collects. That one sentence explains most clinic-pharmacy disputes.
In months one through four, claims climb and collections lag. Insurer payments typically run about a month behind adjudication. So the advance keeps stacking up against a receivable that has not landed.
A hypothetical ledger might look like this:
| Month | Charges | Advance Paid | Collected | Cumulative Over/Under |
|---|---|---|---|---|
| 1 | $40,000 | $6,000 | $0 | -$6,000 |
| 2 | $52,000 | $7,800 | $12,000 | -$1,800 |
| 3 | $58,000 | $8,700 | $38,000 | +$27,500 |
| 4 | $60,000 | $9,000 | $55,000 | +$73,500 |
Collections catch up fast once the first payer cycle clears; above, the balance flips positive by month three.
340B accrual versus cash basis accounting is the difference between recording revenue when a claim is billed and when cash lands. The same statement can show two opposite pictures.
When a statement looks alarming, ask two questions:
340B contract pharmacy reconciliation is matching advance payments, adjudicated claims, and actual collections line by line before the quarterly reevaluation resets your percent. Skip it and you accept whatever number the pharmacy proposes.
Run this every quarter, not just when the ledger looks wrong:
TPA prescriber configurations drift. In one audit, roughly a third of active rendering providers were missing, including the owner, because mid-levels rendered under a supervising NPI or the EHR carried the wrong NPI. That is a reconciliation failure, not a staffing one.
For entities in carve-in states, the reconciliation file must show the Medicaid ID on the HRSA Medicaid Exclusion File. FFS pharmacy claims carry Basis of Cost 08 and Submission Clarification Code 20; ingredient cost is capped at the 340B ceiling price plus the state dispensing fee. Managed care encounters use SCC 20 and 9 per plan spec.
The HRSA Office of Pharmacy Affairs 340B program resources publish the audit expectations that shape what a defensible reconciliation file looks like. The Centers for Medicare & Medicaid Services publish the billing and submission clarification code guidance that governs how 340B claims must be submitted.
The quarterly reevaluation lets the pharmacy adjust the advance percent based on how the ledger has behaved. It is neither automatic nor one-sided.
Three outcomes are typical:
The start-up program and the pharmacy services agreement are two separate documents; ending one does not require ending the other. In programs we run, the exit is a month-by-month sequence modeled before the first notice is drafted.
Skipping a step turns a timing gap into a collection dispute. Order matters more than speed.
Before exiting, build a month-by-month model. Hypothetical: a clinic running $55,000 in monthly 340B claims with a 15% advance and roughly 30% of trailing A/R collected in-month, 70% the next month.
| Month | Charges | Advance Paid | Collected | Cumulative Over/Under |
|---|---|---|---|---|
| 1 | $55,000 | $8,250 | $0 | -$8,250 |
| 2 | $55,000 | $8,250 | $16,500 | $0 |
| 3 | $55,000 | $8,250 | $38,500 | +$30,250 |
| 4 (volume reduced 50%) | $27,500 | $4,125 | $38,500 | +$64,625 |
| 5 (volume reduced 75%) | $13,750 | $2,063 | $19,250 | +$81,813 |
| 6 (notice given) | $0 | $0 | $13,750 | +$95,563 |
Most PSAs we review carry the same core terms. Confirm each in writing before sequencing the exit:
Physical-inventory models can require the clinic to fund roughly one month of COGS unless the pharmacy fronts wholesaler purchases and remits on adjudicated claims; virtual or replenishment models do not carry that float.
Never send a termination notice while the ledger shows the clinic owing. That converts a timing gap into a collection dispute.
Wait for the flip. Then move.
The same errors show up across programs. Most are avoidable with one quarterly habit.
The pharmacy pays the covered entity a fixed percent of monthly charges the following month, regardless of what has actually collected. That creates a cumulative over/under ledger: the clinic receives cash earlier than the underlying claims would support. In ramp months the balance usually shows the clinic owing the pharmacy. Once trailing insurer A/R collects, the balance typically flips to the pharmacy holding clinic margin. Read the ledger on both cash and accrual bases before drawing conclusions.
It is the running difference between advances already paid to the clinic and the amounts that have actually collected on adjudicated claims. When advances exceed collections, the clinic owes the pharmacy; when collections exceed advances, the pharmacy holds clinic margin. The number moves every month, which is why a single statement is not enough. Track it over at least two quarters and reconcile it against your 340B contract pharmacy reconciliation before any program change.
Exit when the ledger shows the pharmacy holding clinic margin and trailing A/R has collected, not when cash flow feels tight. In programs we run, the sequencing that works is: reduce volume first, let A/R collect, request a true-up of the withhold reserve, then give notice. Most pharmacy services agreements allow 60-day no-cause termination and quarterly reconciliation, so the mechanics exist. The mistake is sending notice while the ledger shows the clinic owing.
If you send termination notice while the cumulative over/under shows the clinic owing the pharmacy, you lose leverage on the true-up and may face a clawback during the wind-down. Wait until the balance flips in the clinic's favor and the withhold reserve has been reconciled. Then notice is a routine contract step, not a dispute. Model the transition month by month before signing anything, and keep 2-year post-termination audit rights in mind.
Bring us your patient acquisition, 340B program, or compliance bottleneck. We will show you what a 30-day launch looks like for your clinic — in English or Spanish, month to month, no long contract.
